THB 2.6B. • Strong performance for Combined PET, given COVID disruption, driven by strong PET demand, higher Integrated PET spread, lower costs, improved PIA margin. • Integrated Oxides & Derivatives
not always tally with consolidated financials due to elimination of Intra-company. 3Core EBITDA is Reported EBITDA less Inventory gains/(losses). 7 4Q19 Segment Analysis Integrated PET The overall
quarter driven by resilient sales and margins in Integrated PET, USA PX and PIA businesses. Core net profit grew to THB 1.6B • Core EBITDA grew in all segments and in all regions as our products primarily
downstream business in Integrated Oxides and Derivatives based out of advantaged Gulf Coast USA. Indorama Ventures 2nd Quarter 2019 MD&A 2 2Q 2019 Summary Financials Table 1: Core Financials of Consolidated
always tally with consolidated financials due to elimination of Intra-company. 3Core EBITDA is Reported EBITDA less Inventory gains/(losses). 5 3Q19 Segment Analysis Integrated PET PET volumes are up 22
, registering a growth of 45% QoQ and 21% YoY), positive contract adjustments and inventory gains Our company-wide cost and business transformation, Project Olympus, yielded US$67M during the quarter, on track
3Core EBITDA is Reported EBITDA less Inventory gains/(losses) Indorama Ventures 1st Quarter 2019 MD&A 7 1Q 2019 Performance Analysis Integrated PET (PX, PTA, PET and Recycling) This segment accounted for
-company 3Core EBITDA is Reported EBITDA less Inventory gains/(losses) Indorama Ventures 1st Quarter 2019 MD&A 7 1Q 2019 Performance Analysis Integrated PET (PX, PTA, PET and Recycling) This segment
elimination of Intra-company 3Core EBITDA is Reported EBITDA less Inventory gains/(losses) Indorama Ventures 2018 MD&A 13 Figure 1: Regional Performance 2018 Performance Analysis Integrated PET (PX, PTA, PET
integrated marketing communications where the Company incurred expense to sponsor marketing activities at a cinema in one of major leading shopping center in Bangkok. The Company administrative expense for the